Reports

NewLink Genetics Corporation: NewLink Genetics Reports First Quarter 2016 …
Additionally, there are ongoing clinical development programs and data on induced immune responses targeting non-small-cell lung cancer, melanoma, prostate cancer and kidney cancer. ... studies; its plans related to moving additional indications into ... [...]
6
Like
Save
NewLink Genetics Reports First Quarter 2016 Financial Results
Additionally, there are ongoing clinical development programs and data on induced immune responses targeting non-small-cell lung cancer, melanoma, prostate cancer and kidney cancer. ... studies; its plans related to moving additional indications into ... [...]
1
Like
Save
2016 – Frontier Pharma: Breast Cancer Market Research Review Report: Hexa Reports
The breast cancer pipeline is the largest in the pharmaceutical industry, with 1,050 products in active development across all stages. The range of mechanisms of action employed by these compounds is also highly diverse, especially in comparison to the ... [...]
7
Like
Save
Vitae Pharma Reports Positive Phase 2a Results For Psoriasis Treatment VTP …
“While the autoimmune market is currently dominated by injectable antibody therapy, we believe VTP-43742 has the potential to expand utilization of oral therapy in a variety of autoimmune disorders, such as psoriasis, psoriatic arthritis, rheumatoid ... [...]
7
Like
Save
ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of …
ESSA Pharma is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of castration-resistant prostate cancer ("CRPC") in patients whose disease is progressing despite treatment with current ... [...]
3
Like
Save
US reports first Zika case, transmitted through sex
The unidentified person had not traveled but had sex with a person who had returned from Venezuela and fallen ill with Zika, Dallas County health officials said. The U.S. Centers for Disease Control issued a statement saying lab tests confirmed the ... [...]
5
Like
Save
Colombia reports first Zika-linked deaths
In the first direct statements from government health officials blaming Zika for causing deaths, Colombia's National Health Institute (INS) said the patients died after contracting the virus and developing a rare neurological disorder called Guillain ... [...]
6
Like
Save
Sophiris Bio Reports Encouraging Preliminary Data from Phase 2a Proof of …
The ongoing Phase 2a proof of concept study is a single-center, open-label study at University College London, which is well known for the focal treatment of prostate cancer in the UK. In this study, previously obtained multiparametric magnetic ... [...]
6
Like
Save
Incyte Reports Baricitinib NDA Filing for Rheumatoid Arthritis
We remind investors that in 2009, Incyte and Lilly had entered into an exclusive worldwide license and collaboration agreement to develop and commercialize baricitinib and certain follow-on compounds, for the treatment of patients with inflammatory and ... [...]
5
Like
Save